Device closure of muscular ventricular septal defects in infants less than one year of age using the amplatzer devices: Feasibility and outcome

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 1, 2007, Pages 91-98

  Diab, Karim A ^a   Cao, Qi Ling ^a   Mora, Bassem N ^b   Hijazi, Ziyad M ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Congenital heart disease; Hybrid; Infants; Perventricular; Transcatheter; VSD

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DEVICE; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART VENTRICLE SEPTUM DEFECT; HEMOPERICARDIUM; HUMAN; INFANT; MALE; MEDIASTINITIS; MORBIDITY; NEWBORN; OUTCOME ASSESSMENT; SAFETY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 34447131513     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21142     Document Type: Article

References (29)

1. Anderson RH, Becker AE, Tynan M. Description of ventricular septal defects - Or how long is a piece of string? Int J Cardiol 1986;13:267-278.
2. Serraf A, Lacour-Gayet F, Bruniaux J, Ouaknine R, Losay J, Petit J, Binet JP, Planche C. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg 1992;103:437-442; discussion 443.
3. Kitagawa T, Durham LA III, Mosca RS, Bove EL. Techniques and results in the management of multiple ventricular septal defects. J Thorac Cardiovasc Surg 1998;115:848-856.
4. Hanna B, Colan SD, Bridges ND, Mayer JE, Castenada AR. Clinical and myocardial status after left ventriculotomy for ventricular septal defect closure. J Am Coll Cardiol 1991;17(Suppl):110A.
5. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361-368.
6. Bridges ND, Perry SB, Keane JF, Goldstein SA, Mandell V, Mayer JE Jr, Jonas RA, Castaneda AR, Lock JE. Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med 1991;324:1312-1317.
7. Rigby ML, Redington N. Primary transcatheter closure of perimembranous ventricular septal defect. Br Heart J 1994;72:368-371.
8. Sideris EB, Walsh KP, Haddad JL, Chen CR, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. Heart 1997;77:276-279.
9. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of perimembranous septal defects: Immediate results and intermediate-term follow-up. Am Heart J 1999;138:339-344.
10. Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the Rashkind device: Initial experience. Cathet Cardiovasc Diagn 1999;46:43-48.
11. Bacha EA, Cao QL, Galantowicz ME, Cheatham JP, Fleishman CE, Weinstein SW, Becker PA, Hill SL, Koenig P, Alboliras E, Abdulla R, Starr JP, Hijazi ZM. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol 2005;26:169-175.
12. Diab KA, Hijazi ZM, Cao QL, Bacha EA. A truly hybrid approach to perventricular closure of multiple muscular ventricular septal defects. J Thorac Cardiovasc Surg 2005;130:892-893.
13. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: Initial results and technical considerations. Catheter Cardiovasc Interv 2000;49:167-172.
14. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: Initial clinical applications in children. J Am Coll Cardiol 1999;33:1395-1399.
15. Bacha EA, Cao QL, Starr JP, Waight D, Ebeid MR, Hijazi ZM. Perventricular device closure of muscular ventricular septal defects on the beating heart: Technique and results. J Thorac Cardiovasc Surg 2003;126:1718-1723.
16. Masura J, Walsh KP, Thanopoulos B, Chan C, Bass J, Goussous Y, Gavora P, Hijazi ZM. Catheter closure of moderate-to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: Immediate and short-term results. J Am Coll Cardiol 1998;31:878-882.
17. Wollenek G, Wyse R, Sullivan I, Elliott M, de Leval M, Stark J. Closure of muscular ventricular septal defects through a left ventriculotomy. Eur J Cardiothorac Surg 1996;10:595-598.
18. Amin Z, Gu X, Berry JM, Bass JL, Titus JL, Urness M, Han YM, Amplatz K. New device for closure of muscular ventricular septal defects in a canine model. Circulation 1999;100:320-328.
19. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM, Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a US registry. J Am Coll Cardiol 2004;43:1257-1263.
20. Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM, Hijazi ZM. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 2002;14:322-327.
21. Thanopoulos BD, Karanassios E, Tsaousis G, Papadopoulos GS, Stefanadis C. Catheter closure of congenital/acquired muscular VSDs and perimembranous VSDs using the Amplatzer devices. J Interv Cardiol 2003;16:399-407.
22. Amin Z, Berry JM, Foker JE, Rocchini AP, Bass JL. Intraoperative closure of muscular ventricular septal defect in a canine model and application of the technique in a baby. J Thorac Cardiovasc Surg 1998;115:1374-1376.
23. Stellin G, Padalino M, Milanesi O, Rubino M, Casarotto D, Van Praagh R, Van Praagh S. Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy. Ann Thorac Surg 2000;69:597-601.
24. Fishberger SB, Bridges ND, Keane JF, Hanley FL, Jonas RA, Mayer JE, Castaneda AR, Lock JE. Intraoperative device closure of ventricular septal defects. Circulation 1993;88:II205-II209.
25. Murzi B, Bonanomi GL, Giusti S, Luisi VS, Bernabei M, Carminati M, Vanini V. Surgical closure of muscular ventricular septal defects using double umbrella devices (intraoperative VSD device closure). Eur J Cardiothorac Surg 1997;12:450-454; discussion 454-455.
26. Okubo M, Benson LN, Nykanen D, Azakie A, Van Arsdell G, Coles J, Williams WG. Outcomes of intraoperative device closure of muscular ventricular septal defects. Ann Thorac Surg 2001;72:416-423.
27. Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol 2005;96:52L-58L.
28. Knauth AL, Lock JE, Perry SB, McElhinney DB, Gauvreau K, Landzberg MJ, Rome JJ, Hellenbrand WE, Ruiz CE, Jenkins KJ. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 2004;110:501-507.
29. Moller JH, Patton C, Varco RL, Lillehei CW. Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. Am J Cardiol 1991;68:1491-1497.